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Abstract 
Background: Folate deficiency is rare in western countries and therefore blood tests for folate level have limited 
indications. One such indication is red cell macrocytosis, however it is unclear if the association of macrocytosis with 
folate deficiency is robust enough to serve as a risk marker. Our objective is to determine whether macrocytosis is a 
useful marker for folate deficiency.
Findings: Paired data from the Calgary Laboratory Services Information System was analyzed using receiver operat-
ing characteristic (ROC) curves to determine strength of association between mean corpuscular volume and serum 
folate. Strength of association was analyzed for serum folate cut-off values of 12, 10, 8, and 6 nmol/L. Overall, 0.2% of 
individuals were folate deficient (<6 nmol/L serum folate). Based on ROC curves, at each cut-off level, mean corpuscu-
lar volume was a poor predictive marker for serum folate level.
Conclusions: Folate deficiency is rare in Calgary, Alberta. Macrocytosis is not a strong predictor for folate deficiency.
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Findings
In the late 1990s, Canadian and US federal governments 
mandated folic acid fortification of all commercial wheat 
and cereal-grain products, in the amount of 140  μg 
folate/g [1]. Adherence to this mandate was nearly uni-
versal by January of 1998 [2], resulting in an estimated 
44–64% increase in mean population red blood cell 
(RBC) folate concentration and a 119–161% increase in 
serum folate concentration [3].
Prior to fortification, population estimates for RBC 
folate deficiency were as high as 38%, and 16% for serum 
folate deficiency [4]. Increased risk of folate deficiency 
has been observed in elderly populations, low-income 
and non-white populations [5], and Aboriginal cultures 
[6]. However, recent studies have concluded that for-
tification has resulted in the near-elimination of folate 
deficiency-related anemia in Canada [7, 8]. Despite this, 
tests for serum folate levels are still commonly ordered 
by Canadian physicians.
The purpose of this study is twofold: firstly, to docu-
ment the rate of folate deficiency among serum folate 
tests ordered in Calgary, Alberta; and secondly, to deter-
mine whether red cell mean corpuscular volume (MCV) 
can reliably be used as a marker for folate deficiency. 
Macrocytosis associated with megaloblastic anemia has 
been tied to both B12 and folate deficiency [9], which 
has prompted questions regarding the necessity of folate 
testing for patients that do not exhibit anemia-related 
macrocytosis.
This research was approved by the University of Cal-
gary Conjoint Research Ethics Board (ID: REB 13-0376). 
We examined data on paired folate levels and MCV in the 
Calgary Laboratory Services Laboratory (CLS) Informa-
tion System database for the period of 01 January 2010 
to 30 September 2013. CLS is the sole provider of labo-
ratory testing for the Calgary Health Region in Southern 
Alberta (catchment population of 1.4 million people). The 
extracted data included values for vitamin B12, MCV, 
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and serum folate level. RBC folate was rarely measured 
and was not considered in this study. As we were inter-
ested only in the association of MCV and folate level, 
we included only patients with a B12 level in the normal 
range for our laboratory (greater than 155 pmol/L).
Receiver operating characteristic (ROC) curves were 
used to analyze the association between MCV and serum 
folate values, with the area under the curve (AUC) rep-
resenting the strength of this correlation. An AUC of 0.8 
is considered a strong correlation (the theoretical maxi-
mum value being 1), while an AUC in the 0.5–0.6 range 
is typically indicative of a non-predictive or random dis-
tribution [10]. We performed the AUC analysis for four 
threshold values for serum folate: <12 nmol/L (the lower 
limit of normal for Alberta Health Services), <6 nmol/L 
(the level considered deficient by Colaptino et al. [7]), and 
two intermediate values of <10 and <8 nmol/L. For every 
serum folate level we looked for an MCV value tested 
within ±7  days. To avoid pseudoreplication, only one 
(the first in this date range) paired folate-MCV test was 
included for each individual. To avoid a possible bias of 
macrocytosis due to vitamin B12 deficiency, all individu-
als with a vitamin B12 level <155 pmol/L were excluded 
from the analysis.
Paired folate and MCV vales were available for a total 
of 46,827 individuals (27,021 women and 19,805 men). 
For the purposes of analysis folate values reported as 
>45.4  nmol/L (the upper limit of our reporting range) 
were converted to 45.4  nmol/L. The mean age was 56.9 
and the mean serum folate level was 33.2  nmol/L. 3.6% 
of individuals had a folate value of <12 nmol/L (the lower 
normal range in Alberta laboratories). However, for a 
folate cutoff value of <6 nmol/L—the cutoff for deficiency 
used by Colapinto et  al. [7]—only 0.2% of individuals 
were considered deficient. The ROC analysis showed that 
for a threshold value of <12  nmol/L serum folate com-
pared against MCV, the AUC was 0.575; for a threshold 
value of 10 nmol/L serum folate, the AUC was 0.582; for 
a threshold value of 8 nmol/L serum folate, the AUC was 
0.626; finally, for a threshold value of 6  nmol/L serum 
folate, the AUC was 0.613 (Fig. 1). Finally, we examined 
the potential contributions of age, sex, hemoglobin level 
and ferritin level (as a measure of co-existing iron defi-
ciency) using a binary logistic regression. We conducted 
this analysis on a subset of 22,347 individuals for which 
full data was available. The results are shown in Table 1. 
This analysis showed that men were more likely to be 
macrocytic than women (OR 0.788) and lower folate 
levels were modestly associated with macrocytosis (OR 
0.99). Hemoglobin was not associated with macrocy-
tosis in this model and Vitamin B12 level, age and fer-
ritin, although statistically significant were associated 
with odds ratios close to 1. The lack of association with 
vitamin B12 level was not surprising as B12 deficiency 
was an exclusion criteria for the study.
Using a cutoff value of <6 nmol/L we observed a defi-
ciency rate of 0.2%. This is 20% of the deficiency rate 
reported in a previous Canadian study [7]. The reason for 
this is unclear. It may be due to either a lower deficiency 
rate within Calgary as compared to the Canadian popu-
lation at large, or it may be due to a mismatch between 
testing effort and at risk individuals.
None of the AUC values we obtained for the four com-
parisons of MCV and serum folate suggested a strong 
level of association. Therefore, despite the well-known 
association between folate deficiency and macrocytosis, 
our results indicate that macrocytosis is at best a weak 
marker for folate deficiency and cannot be used to screen 
for folate deficiency.
There are several limitations to this study. First of all, 
as we did not use a random sample of individuals but 
rather considered all tests done at our lab, the preva-
lence we report cannot be directly compared with previ-
ous work. Further work is needed to distinguish between 
Fig. 1 Receiver operator characteristic curves for red blood cell mean 
corpuscular volume (MCV) and serum folate deficiency using the cut-
off values of <12, <10, <8, and <6 nmol/L for serum folate. All cut-off 
values show a poor relationship between MCV and folate deficiency 
(areas under the curve are given in the text).
Table 1 Binary logistic regression model showing the 
association of  independent associations of  serum folate 
level, hemoglobin level, vitamin B12 level, age, ferritin 
level, and sex with the presence of RBC macrocytosis (MCV 
>100)
Variable P value OR (95% CI)
Serum folate level <0.001 0.990 (0.986–0.984)
Hemoglobin level 0.141 0.999 (0.999–1.004)
Vitamin B12 level <0.001 1.000 (1.000–1.001)
Age <0.001 1.023 (1.021–1.026)
Serum ferritin level <0.001 1.001 (1.001–1.001)
Sex (female) 0.004 0.788 (0.788–0.957)
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these possibilities. A second limitation is that other than 
vitamin B12 deficiency, we did not have data on other 
possible causes of macrocytosis such as medications and 
myeloproliferative disorders. We did not have data on 
levels of methylmalonic acid or homocysteine which may 
have indicated occult vitamin B12 or folate deficiency. It 
is possible that other causes of macrocytosis could have 
weakened any relationship in our data.
Taken in context with other recent work on folate defi-
ciency in Canada, our results indicate that while folate 
deficiency is rare in Canada, macrocytosis is not a useful 
marker for its presence.
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